-
1 Comment
Shenzhen Kangtai Biological Products Co., Ltd is currently in a long term downtrend where the price is trading 9.2% below its 200 day moving average.
From a valuation standpoint, the stock is 395.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 47.7.
Shenzhen Kangtai Biological Products Co., Ltd's total revenue sank by 6.2% to $550M since the same quarter in the previous year.
Its net income has increased by 0.5% to $174M since the same quarter in the previous year.
Finally, its free cash flow grew by 129.6% to $200M since the same quarter in the previous year.
Based on the above factors, Shenzhen Kangtai Biological Products Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| ISIN | CNE100002Q33 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | CNY |
| PE Ratio | 280.83 |
|---|---|
| Target Price | 19.095 |
| Dividend Yield | 0.5% |
| Beta | 0.94 |
| Market Cap | 19B |
Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. The company's marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanus and acellular pertussis combined vaccine, adsorbed, rabies vaccine (human diploid cell) for human use, hib conjugate vaccine, measles and rubella combined vaccine, sars-cov-2 vaccine, inactivated, and covid-19 vaccine. Its research and development vaccines comprise measles, mumps and rubella vaccine, 2DTAP- HIB-IPV, 4-valent influenza (split), poliomyelitis vaccine (vero cells), and inactivated, sabin strain. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300601.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
